SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN AORTITIS ASSOCIATED WITH GIANT CELL ARTERITIS: MULTICENTER STUDY OF 196 PATIENTS

Autoimmune Disease
Do you want to read an article? Please log in or register.